MIRADRY SYSTEM MN-MD4000-MC-GB

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2020-02-21 for MIRADRY SYSTEM MN-MD4000-MC-GB manufactured by Miradry, A Sientra Company.

Event Text Entries

[180784310] Patient experienced redness and swelling, was started on augmentin 625mg tds for 1 week, by day 3 the redness around the arm was spreading and the mass was fluctuant. Patient was admitted to the new (b)(6). Under general anaesthesia the md carried out an incision and drainage of the abscess, which was the size of a grape, and packed with betadine and gauze. Patient was discharged the following morning after redness had resolved.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3008082710-2020-00008
MDR Report Key9742452
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2020-02-21
Date of Report2020-02-21
Date of Event2020-01-06
Date Mfgr Received2020-01-23
Date Added to Maude2020-02-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJOANN KUHNE
Manufacturer Street420 S FAIRVIEW AVE. SUITE 200
Manufacturer CitySANTA BARBARA, CA
Manufacturer CountryUS
Manufacturer Phone5623500
Manufacturer G1SIENTRA, INC.
Manufacturer Street420 S FAIRVIEW AVE. SUITE 200
Manufacturer CitySANTA BARBARA, CA
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMIRADRY SYSTEM
Generic NameMICROWAVE DERMATOLOGIC SYSTEM
Product CodeOUB
Date Received2020-02-21
Model NumberMN-MD4000-MC-GB
Catalog NumberMN-MD4000-MC-GB
Lot Number17H0292
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMIRADRY, A SIENTRA COMPANY
Manufacturer Address420 S FAIRVIEW AVE. SUITE 200 SANTA BARBARA, CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-02-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.